Patents by Inventor Paul Vincent Fish

Paul Vincent Fish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3-Heterocyclylpropanohydroxamic acids
    Publication number: 20030119807
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: July 16, 2002
    Publication date: June 26, 2003
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • 3-heterocyclylpropanohydroxamic acid PCP inhibitors
    Publication number: 20030069291
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: March 29, 2002
    Publication date: April 10, 2003
    Inventors: Simon Bailey, Paul Vincent Fish, Kim James, Gavin Alistar Whitlock
  • 3-heterocyclylpropanohydroxamic acid PCP inhibitors
    Publication number: 20020187979
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: March 29, 2002
    Publication date: December 12, 2002
    Inventors: Paul Vincent Fish, Jackie Diane Kendall, Gavin Alistair Whitlock
  • Procollagen C-proteinase inhibitors
    Patent number: 6448278
    Abstract: Compounds of formula (I): and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: September 10, 2002
    Assignee: Pfizer Inc.
    Inventors: Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson
  • (7-(3-Carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine
    Publication number: 20020077336
    Abstract: The invention described herein relates to a process for the preparation of (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine (I), intermediates thereto and new forms and formulations thereof, including the zwitterion monohydrate of (I), suitable for pharmaceutical use.
    Type: Application
    Filed: October 29, 2001
    Publication date: June 20, 2002
    Inventors: Anne Bruckner, Michael Butters, Paul Vincent Fish, Michael Paul Fitzgerald, Julie Ann Macrae, Trevor Jack Newbury, Richard Anthony Storey
  • Procollagen C-proteinase inhibitors
    Publication number: 20010021718
    Abstract: 1
    Type: Application
    Filed: December 13, 2000
    Publication date: September 13, 2001
    Inventors: Simon Bailey, Stephane Billotte, Andrew Michael Derrick, Paul Vincent Fish, Kim James, Nicholas Murray Thomson
  • Isoquinolines as urokinase inhibitors
    Patent number: 6248738
    Abstract: Compounds of formula (I): and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N═C(NH2)2 or NHC(═NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: June 19, 2001
    Assignee: Pfizer Inc.
    Inventors: Roger Peter Dickinson, Christopher Gordon Barber, Paul Vincent Fish
  • Isoquinolines
    Patent number: 6093731
    Abstract: Isoquinolinylguanidine compounds of formula (I): ##STR1## wherein the substituents are as defined herein, and salts thereof, are disclosed as urokinase inhibitors.
    Type: Grant
    Filed: July 22, 1999
    Date of Patent: July 25, 2000
    Inventors: Roger Peter Dickinson, Paul Vincent Fish, Christopher Gordon Barber
  • Antithrombotic n-amidinopiperidine and benzamidine derivatives
    Patent number: 5917034
    Abstract: Compounds of formula (I), pharmaceutically acceptable salts thereof, and pharmaceutically acceptable solvates of either entity, wherein A is optionally monosaturated C.sub.1 -C.sub.4 alkylene optionaly monounsaturatred with C.sub.1 -C.sub.4 alkyl; B is C.sub.1 -C.sub.3 alkylene optionally substituted with C.sub.1 -C.sub.4 alkyl; R.sup.1 is N-amidino-4-piperidyl or 4-amidinophenyl; R.sup.2 is C.sub.4 -C.sub.12 alkyl; (C.sub.3 -C.sub.8 cycalkyl)C.sub.1 -C.sub.4 alkylene; optionally methylene-bridged C.sub.5 -C.sub.8 cycloalkyl optionally substituted with one to three C.sub.1 -C.sub.4 alkyl groups or with hydroxy; C.sub.5 -C.sub.8 alkenyl; C.sub.5 -C.sub.8 cycloalkenyl optionally subsituted with C.sub.1 -C.sub.4 alkyl; piperidyl N-substituted with C.sub.1 -C.sub.4 alkyl; tetrahydrothiopyranyl or tetrahydropyranyl; and R.sup.3 is H or C.sub.1 -C.sub.4 alkyl optionally substituted with C.sub.1 -C.sub.4 alkoxy or with hydroxy; or R.sup.2 and R.sup.
    Type: Grant
    Filed: March 9, 1998
    Date of Patent: June 29, 1999
    Assignee: Pfizer Inc.
    Inventors: Alan Daniel Brown, John Christopher Danilewicz, Paul Vincent Fish